<DOC>
	<DOCNO>NCT00814476</DOCNO>
	<brief_summary>Randomized , two arm , control , open study comprise two consecutive segment . At first segment last first 4 month study , patient randomize Care link treat group non Care link treat group . At segment study usage Care link system accompany diabetic team , least monthly contact via Internet initiate diabetic team . At second segment study , follow 4 month , group use Care link System , home-use , without support initiate diabetic team .</brief_summary>
	<brief_title>The Effects Regular Home Use Vs Diabetic Team- Supported Use Medtronic CareLink Therapy Management System .</brief_title>
	<detailed_description>A randomize , two arm , control , open study order compare efficacy , short long term effect regular home-use Vs diabetic team- support use Medtronic CareLink therapy management system patient diabetes . Primary objective : To assess efficacy , short term ( 4 month ) long term ( 8 month ) effect use Medtronic CareLink® Therapy Management System Diabetes follow parameter : 1 . Metabolic control express HbA1c . 2 . Hypoglycemic events- number severity episode . 3 . DKA ketosis events- number severity episode . 4 . Patient 's satisfaction quality life measure treatment satisfaction quality life questionnaire . 5 . 7 point glucose profile . Secondary objective : To compare efficacy 4 month treatment use CareLink® Therapy Management System , accompany intensive contact ( least month ) initiate diabetic team via internet/electronic mail Vs home use treatment - without monthly contact initiate diabetic team Study design : The study comprise two consecutive segment . At first segment last first 4 month study , patient randomize CareLink treat group non CareLink treat group . At segment study usage CareLink system accompany diabetic team , least monthly contact via internet initiate diabetic team . At second segment study , follow 4 month , group use CareLink system , home-use , without support initiate diabetic team .</detailed_description>
	<criteria>1 . Type 1 diabetes diagnose least 6 month prior study entry 2 . Current treatment Medtronic 722 /712 external insulin pump system 3 . Treatment insulin pump least 3 month prior study entry 4 . An internet access patient 's home 5 . Age 035 year old 6 . HbA1c &gt; 7.8 7 . Signing inform consent form 1 . Any significant disease condition , include psychiatric disorder opinion investigator likely effect compliance ability complete study 2 . Patients participate device drug study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Medtronic CareLink</keyword>
	<keyword>therapy management</keyword>
	<keyword>diabetes</keyword>
	<keyword>insulin pump</keyword>
	<keyword>Blood glucose monitor</keyword>
</DOC>